The AGH Brain Tumor Center provides both inpatient and consultative care for brain tumor patients throughout Western Pennsylvania and is in the lead position to advance neuro-oncological care throughout the 6 hospitals (1800 beds) of the West Penn Allegheny Health System. Coordinated care is provided by a dedicated team of a board-certified neuro-oncologist, neuro-surgeons, radiation oncologists, and medical oncologists. The team provides comprehensive evaluation and treatment of newly diagnosed and recurrent primary or metastatic brain tumors. Long term neurological follow up of brain cancer survivors is coordinated and managed.
What neuro-oncological conditions do we treat?
- Primary Brain Tumors in adults: Glioblastoma Multiforme, Astrocytoma, Oligodendroglioma, Ependymoma, Medulloblastoma and others
- Primary Central Nervous System Lymphoma
- Metastatic brain tumors
- Seizures due to brain tumors
- Cognitive disorders due to brain tumors
- Late neurological complications of brain tumor therapy
- Neurological effects of cancer treatments
- Central nervous system autoimmune or inflammatory conditions requiring chemotherapeutic treatment
- Paraneoplastic Syndromes due to systemic cancer
- Pituitary Adenomas or malignancy
- Carcinomatous meningitis
Neuroimaging capabilities (24 hour services) at the AGH main campus include:
- 3 MRI scanners (1.5 Tesla)
- 4 CT Scanners
- Nuclear medicine CT/PET scanner and SPECT scanning
Neuroscience Units at the AGH Main Campus include:
- 23 bed Neurointensive Care Unit
- 42 bed Neuroscience Unit
- 36 bed telemetry monitored unit
Referrals: 412-359-8848 or 412-359-8850
